Evidence map›Paper›PMID 27754434›Full record

ReviewMolecules (Basel, Switzerland)2016

Enzyme Engineering for In Situ Immobilization.

Fabian B H Rehm, Shuxiong Chen, Bernd H A Rehm

Abstract readReview
In one paragraph

Review in Molecules (Basel, Switzerland), 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Review
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Immobilization ofFood technology and biotechnology · 2022
    Article
  16. Review
  17. Article
  18. Review
  19. Novel ChaperonesMolecules (Basel, Switzerland) · 2020
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Fabian B H RehmInstitute of Fundamental Sciences, Massey University, Private Bag 11222, Palmerston North 4442, New Zealand. F.Rehm@massey.ac.nz.
Shuxiong ChenInstitute of Fundamental Sciences, Massey University, Private Bag 11222, Palmerston North 4442, New Zealand. S.X.Chen@massey.ac.nz.
Bernd H A RehmInstitute of Fundamental Sciences, Massey University, Private Bag 11222, Palmerston North 4442, New Zealand. B.Rehm@massey.ac.nz.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Enzymes are used as biocatalysts in a vast range of industrial applications. Immobilization of enzymes to solid supports or their self-assembly into insoluble particles enhances their applicability by strongly improving properties such as stability in changing environments, re-usability and applicability in continuous biocatalytic processes. The possibility of co-immobilizing various functionally related enzymes involved in multistep synthesis, conversion or degradation reactions enables the design of multifunctional biocatalyst with enhanced performance compared to their soluble counterparts. This review provides a brief overview of up-to-date in vitro immobilization strategies while focusing on recent advances in enzyme engineering towards in situ self-assembly into insoluble particles. In situ self-assembly approaches include the bioengineering of bacteria to abundantly form enzymatically active inclusion bodies such as enzyme inclusions or enzyme-coated polyhydroxyalkanoate granules. These one-step production strategies for immobilized enzymes avoid prefabrication of the carrier as well as chemical cross-linking or attachment to a support material while the controlled oriented display strongly enhances the fraction of accessible catalytic sites and hence functional enzymes.

Indexed as

BacteriaBiocatalysisEnzymesEnzymes, ImmobilizedEnzyme StabilityInclusion BodiesPolyhydroxyalkanoatesProtein EngineeringEnzymesEnzymes, ImmobilizedPolyhydroxyalkanoatesbiocatalystenzymeimmobilizationinclusion bodiesprotein particlesrecombinant enzymeself-assembly

Identifiers

PMID27754434
PMCPMC6273058

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.